| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892 [A. C. H., P. A. E., C. P. F., L. L. H., S. S. T.], and Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 [D. R.]
The temporary maintenance of a rat liver epithelial cell population at confluence before passaging followed by periods of rapid proliferation resulted in the generation of spontaneous transformants after about 108 population doublings. The appearance of morphologically aberrant transformants correlated directly with an increased resistance of the population to the growth inhibitory effects of transforming growth factor ß1 (TGF-ß1). Clonal cell lines derived from the transformants were resistant to TGF-ß1 dependent inhibition of DNA synthesis. These cell lines were also highly tumorigenic and aneuploid, with characteristic gross chromosomal abnormalities, and they expressed a number of phenotypic markers common to rat liver epithelial cells transformed by oncogenes or chemicals. In contrast, apparently normal looking cell lines cloned from the same population were nontumorigenic and near diploid, with few chromosomal abnormalities, and they were as sensitive to TGF-ß1 as early passage normal rat liver epithelial cells. Morphologically normal late passage rat liver epithelial cells were sensitive to transformation by the DNA hypomethylating agent 5-aza-2-deoxycytidine, in contrast to earlier passage cells, and this transformation was accompanied by the development of resistance to the growth inhibitory effects of TGF-ß1. These findings suggest that acquisition of resistance to the effects of growth inhibitors such as TGF-ß1 is an important and possibly essential stage in the spontaneous transformation of rat liver epithelial cells.
1 Present address: Nestlé Research Centre, Vers-Chez-Les-Blanc, P.O. Box 44, 1000 Lausanne 26, Switzerland.
2 To whom requests for reprints should be addressed, at Laboratory of Experimental Carcinogenesis, National Cancer Institute, Building 37, Room 3C28, Bethesda, MD 20892.
Received 6/ 3/91. Accepted 8/21/91.
This article has been cited by other articles:
![]() |
J. Gotzmann, H. Huber, C. Thallinger, M. Wolschek, B. Jansen, R. Schulte-Hermann, H. Beug, and W. Mikulits Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-{beta}1 and Ha-Ras: steps towards invasiveness J. Cell Sci., March 15, 2002; 115(6): 1189 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Foster Cell Death and Cell Proliferation in the Control of Normal and Neoplastic Tissue Growth Toxicol Pathol, May 1, 2000; 28(3): 441 - 446. [Abstract] [PDF] |
||||
![]() |
E. A. Conner, T. Teramoto, P. J. Wirth, A. Kiss, S. Garfield, and S. S. Thorgeirsson HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1 Carcinogenesis, April 1, 1999; 20(4): 583 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hooth, W. B. Coleman, S. C. Presnell, K. M. Borchert, J. W. Grisham, and G. J. Smith Spontaneous Neoplastic Transformation of WB-F344 Rat Liver Epithelial Cells Am. J. Pathol., December 1, 1998; 153(6): 1913 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gerdes, M. Larsen, L. McBride, T. D. Dang, B. Lu, and D. R. Rowley Localization of Transforming Growth Factor-b1 and Type II Receptor in Developing Normal Human Prostate and Carcinoma Tissues J. Histochem. Cytochem., March 1, 1998; 46(3): 379 - 388. [Abstract] [Full Text] |
||||
![]() |
B. A. Jones and G. J. Gores Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Arima, C.-Y. Kao, T. Licht, R. Padmanabhan, Y. Sasaguri, and R. Padmanabhan Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A J. Biol. Chem., April 13, 2001; 276(16): 12675 - 12684. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |